Clinical Trials on Benign Prostatic Hypertrophy

Total 8725 results

Oculus Innovative Sciences, Inc.

Unknown

A Substantial Equivalence Study of RD04723 and Predicate Device

Hypertrophic Scar | Keloid Scar

United States
Medi-Tate Ltd.

Completed

Study to Assess the Efficacy of Medi-Tate iTind Device

Benign Prostatic Hyperplasia (BPH)

Spain, Belgium, Italy, Switzerland, United Kingdom
GemVax & Kael

Completed

A Phase II Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Patients With BPH

Benign Prostatic Hyperplasia (BPH)

Korea, Republic of
University of Kansas Medical Center

Enrolling by invitation

SOLTIVE™ Laser Enucleation for Treatment of Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia | BPH

United States
Eli Lilly and Company

Terminated

A Study in Men With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, Germany, France, Australia, Greece, Canada, Russian Federation, Italy
Brooklyn Urology Research Group
American Medical Systems; Richard Wolf Medical Instruments Corporation (RWMIC)

Completed

Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia (BPH)

United States
Daniel Stephan Engeler

Completed

A Prospective Investigation Using the Expired Breath Ethanol Test

Benign Prostatic Hyperplasia (BPH)

Switzerland
HistoSonics, Inc.

Withdrawn

Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (Canada)

Benign Prostatic Hyperplasia (BPH)
Samsung Medical Center
The Korean Urological Association

Withdrawn

The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Korea, Republic of
Watson Pharmaceuticals

Completed

A New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo

Benign Prostatic Hyperplasia (BPH)

United States
Kissei Pharmaceutical Co., Ltd.

Completed

A Comparative Study of KSO-0400 in BPH Patients With LUTS

Benign Prostatic Hyperplasia (BPH)

Japan
Lawson Health Research Institute
Gyrus ACMI, Inc.

Completed

Bipolar vs Monopolar Transurethral Resection of the Prostate (TURP)

Benign Prostatic Hyperplasia | BPH

Canada
Istanbul University

Completed

Bipolar Versus Monopolar Resection of Benign Prostate Hyperplasia

Acute Hyponatremia

Turkey
Massachusetts General Hospital
Shriners Hospitals for Children

Unknown

Laser Therapy for Treating Hypertrophic Burn Scars in Children (LaserTherapy)

Burn Scars

United States
Medstar Health Research Institute

Completed

Characterization of Dyschromic Hypertrophic Scar

Burn Scar | Hyperpigmentation | Hypertrophic Scar | Hypopigmented Scar

United States
Astellas Pharma Korea, Inc.

Completed

Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate) (POST-TURP)

Overactive Bladder | Benign Prostate Hyperplasia | Transurethral Resection of Prostate | Photoselective Vaporization Prostatectomy

Korea, Republic of
University of Calgary
IMBiotechnologies Ltd.

Not yet recruiting

Evaluate the Safety and Effectiveness of Using Echogenic Embolic Agent for Embolization of Prostate Artery for Treatment of Men With BPH (PAE CEUS) (PAE CEUS)

Benign Prostatic Hyperplasia
Urotronic Inc.
ClinLogix. LLC

Active, not recruiting

A Clinical Study to Evaluate the Safety and Efficacy of the Optilume™ BPH Catheter System in Men With Symptomatic BPH (PINNACLE)

Benign Prostatic Hyperplasia

United States, Canada
Kasr El Aini Hospital

Completed

Low Power ThULEP for Prostate Size More Than 80 gm

Benign Prostatic Hyperplasia

Egypt
Assistance Publique - Hôpitaux de Paris
Ministry of Health, France

Completed

Prostatic Artery Embolization Versus Medical Treatment in Symptomatic Benign Prostatic Hyperplasia (PARTEM)

Benign Prostatic Hyperplasia

France
Organon and Co

Completed

A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)

Benign Prostatic Hyperplasia
ProstaCare Singapore Pte. Ltd.

Terminated

To Evaluate the Safety and Performance of the ProstaCare Water Electrolysis System in Relieving Symptoms of BPH.

Benign Prostatic Hyperplasia

Singapore, New Zealand
OPKO Health, Inc.

Terminated

Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

United States
Zenflow, Inc.

Active, not recruiting

The Zenflow Spring System Safety, Performance and Effectiveness Study (ZEST2)

Benign Prostatic Hyperplasia

Mexico
Boston University

Terminated

Laser Enucleation of Prostate (LEP) Versus Transurethral Resection of Prostate (TURP)

Benign Prostatic Hyperplasia

United States
University of Kansas Medical Center

Unknown

Early Apical Release vs Classic Holmium Laser Enucleation of the Prostate: Randomized Controlled Trial Comparing Post-Operative Incontinence Rates and Surgical Outcomes (HoLEP EAR)

Benign Prostatic Hyperplasia

United States
NeoTract, Inc.

Completed

Urodynamic Feasibility Study Utilizing the UroLift® System (UDS)

Benign Prostatic Hyperplasia

United States
Boehringer Ingelheim

Completed

Real World Data on Management of Male LUTS

Benign Prostatic Hyperplasia

United States
Zhujiang Hospital
The First Affiliated Hospital of Anhui Medical University; The First Affiliated... and other collaborators

Unknown

Transurethral Plasmakinetic Enucleation of Prostate Versus Transurethral Resection of Prostate (ERP)

Benign Prostatic Hyperplasia

China
Saint-Joseph University

Completed

A Pumpkin Seed, Isoflavonoid and Cranberry Mix in LUTS/BPH

Benign Prostatic Hyperplasia

Lebanon
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Completed

Efficacy of Silodosin in the Treatment of Symptomatic Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

Bangladesh
Allergan

Completed

Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

France, Poland, Korea, Republic of, Canada, United States, Germany, Philippines, Czechia
Zenflow, Inc.

Unknown

The Zenflow Spring System Feasibility and Safety Study (ZEST)

Benign Prostatic Hyperplasia

Bulgaria, New Zealand
Sophiris Bio Corp

Completed

Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia (TRIUMPH-1)

Benign Prostatic Hyperplasia

Canada
NeoTract, Inc.

Completed

The Safety and Effectiveness of UroLift: LIFT Pivotal Study (LIFT)

Benign Prostatic Hyperplasia

United States, Australia, Canada
IRCCS San Raffaele

Unknown

Outcomes and Complications of Holmium Laser Enucleation of the Prostate in Expert Hands (ExpHo)

Benign Prostatic Hyperplasia

Italy
JW Pharmaceutical

Completed

Observational Study to Evaluate Effect of Thrupas® Capsule on Cardiovascular System (CV)

Benign Prostatic Hyperplasia

Korea, Republic of
NeoTract, Inc.

Completed

BPH-6: Comparison of the UroLift System to TURP for Benign Prostatic Hyperplasia (BPH-6)

Benign Prostatic Hyperplasia

Denmark, United Kingdom, Germany
PROCEPT BioRobotics

Completed

AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia (ABS)

Benign Prostatic Hyperplasia

India
University of Alberta
Merck Frosst Canada Ltd.

Withdrawn

On Label, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Finasteride in Patients Undergoing Transurethral Resection of the Prostate (TURP)

Benign Prostatic Hyperplasia

Canada
Chong Kun Dang Pharmaceutical

Completed

Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients

Benign Prostatic Hyperplasia

Korea, Republic of
Eli Lilly and Company
Nippon Shinyaku Co., Ltd.

Completed

A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).

Benign Prostatic Hyperplasia

Japan
Beni-Suef University

Completed

Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients.

Benign Prostatic Hyperplasia

Egypt
University Hospital, Rouen

Terminated

Results of Selective Prostatic Arterial Embolization in Patients With Indwelling Urinary Catheter Due to Benign Prostatic Hyperplasia Refractory to Medical Treatment. (Prost-EMBOL)

Benign Prostatic Hyperplasia

France
Assistance Publique - Hôpitaux de Paris

Completed

QUAPELLA (QUAlity of Prostate Enucleation by LUMENIS - Laser) (QUAPELLA)

Benign Prostatic Hyperplasia

France
Nymox Corporation

Completed

Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia

United States
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United Kingdom, Taiwan, Korea, Republic of, Canada, Slovakia, France, Italy, Austria, Czech Republic, Australia, Germany
QLT Inc.

Completed

Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States, Canada
Samsung Medical Center

Unknown

Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia
Eli Lilly and Company

Completed

Pilot Study Investigating Safety and Efficacy of Tadalafil as Treatment for Benign Prostatic Hyperplasia (BPH) in Asian Men

Benign Prostatic Hyperplasia

Korea, Republic of

Clinical Trials on Benign Prostatic Hypertrophy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations